Motif ID: Tcf21_Msc
Z-value: 1.207
Transcription factors associated with Tcf21_Msc:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Msc | ENSMUSG00000025930.5 | Msc |
| Tcf21 | ENSMUSG00000045680.7 | Tcf21 |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.9 | 17.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 4.4 | 13.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
| 3.2 | 12.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 2.3 | 11.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 2.2 | 6.5 | GO:0036292 | DNA rewinding(GO:0036292) |
| 2.1 | 6.4 | GO:2000564 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) CD8-positive, alpha-beta T cell proliferation(GO:0035740) negative regulation of regulatory T cell differentiation(GO:0045590) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 1.8 | 12.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.8 | 5.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) renal vesicle induction(GO:0072034) |
| 1.8 | 15.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 1.7 | 5.1 | GO:0003032 | detection of oxygen(GO:0003032) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.5 | 6.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.5 | 4.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 1.4 | 8.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.3 | 4.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 1.3 | 3.8 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.2 | 3.5 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 1.2 | 3.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
| 1.1 | 5.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 1.1 | 4.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.1 | 10.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.0 | 2.9 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 1.0 | 1.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.0 | 10.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 1.0 | 4.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.0 | 2.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.9 | 2.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.9 | 3.7 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.9 | 2.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.9 | 4.4 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.8 | 4.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.8 | 4.9 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.8 | 2.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.7 | 8.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.7 | 4.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.7 | 6.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.7 | 7.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.7 | 6.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.7 | 2.0 | GO:1900275 | B cell proliferation involved in immune response(GO:0002322) negative regulation of phospholipase C activity(GO:1900275) |
| 0.7 | 2.6 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.6 | 9.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.6 | 6.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.6 | 2.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.6 | 6.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.6 | 5.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 | 1.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.6 | 1.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.6 | 2.8 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.5 | 5.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.5 | 3.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
| 0.5 | 2.6 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.5 | 1.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.5 | 2.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.5 | 3.9 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.5 | 3.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.5 | 1.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.5 | 2.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.5 | 4.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.5 | 8.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.4 | 4.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.4 | 1.3 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.4 | 1.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.4 | 1.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 1.7 | GO:1904426 | positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.4 | 3.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.4 | 2.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.4 | 5.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.4 | 5.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 | 1.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.4 | 1.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 | 1.1 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.4 | 2.8 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.3 | 2.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 | 5.5 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.3 | 1.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 0.7 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.3 | 2.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.3 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 1.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 | 8.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.3 | 5.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.3 | 2.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 1.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.3 | 11.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.3 | 2.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 | 1.8 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.3 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 4.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.3 | 9.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.3 | 1.7 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 4.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 1.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.3 | 1.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 6.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.3 | 3.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 3.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 | 2.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.3 | 6.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 5.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.2 | 0.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.2 | 2.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 6.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 | 2.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 21.3 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.2 | 1.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.2 | 8.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.2 | 2.6 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 2.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 | 3.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.2 | 2.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 0.2 | 1.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 | 0.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
| 0.2 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 2.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 | 2.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.8 | GO:0032911 | nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 4.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.2 | 1.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 2.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 | 0.8 | GO:0071205 | clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 | 5.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 0.9 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
| 0.2 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.2 | 3.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 1.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 | 1.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 | 10.4 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.1 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 1.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.1 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 1.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.1 | 6.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.1 | 2.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 1.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 1.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 1.4 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.6 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
| 0.1 | 1.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 | 1.4 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 | 0.4 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.1 | 2.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.1 | 3.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 2.0 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
| 0.1 | 0.4 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 2.0 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.1 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 1.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 2.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 4.5 | GO:0007569 | cell aging(GO:0007569) |
| 0.1 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.3 | GO:0097531 | mast cell migration(GO:0097531) |
| 0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 1.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 2.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 1.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.1 | 4.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 1.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.0 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
| 0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 | 0.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 2.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.0 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 1.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 1.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 | 0.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 2.6 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
| 0.0 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.0 | 3.1 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.0 | 1.4 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
| 0.0 | 3.7 | GO:0090132 | epithelial cell migration(GO:0010631) tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.0 | 2.0 | GO:0015992 | proton transport(GO:0015992) |
| 0.0 | 0.1 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.0 | 0.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 4.3 | GO:0043010 | camera-type eye development(GO:0043010) |
| 0.0 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 | 0.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) actin filament severing(GO:0051014) |
| 0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.0 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 1.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 1.6 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 | 1.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
| 0.0 | 1.0 | GO:0051297 | centrosome organization(GO:0051297) |
| 0.0 | 0.5 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 0.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 0.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 13.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 3.2 | 12.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 2.1 | 8.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 1.3 | 3.8 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.1 | 5.3 | GO:0001651 | dense fibrillar component(GO:0001651) box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 1.0 | 3.8 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.9 | 4.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.9 | 6.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.8 | 5.0 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.7 | 4.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) neurofibrillary tangle(GO:0097418) |
| 0.6 | 1.2 | GO:0030894 | replisome(GO:0030894) |
| 0.6 | 4.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.5 | 1.5 | GO:0070449 | elongin complex(GO:0070449) |
| 0.5 | 6.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.4 | 4.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.4 | 3.5 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 3.9 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.4 | 1.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.4 | 1.7 | GO:1990795 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 0.4 | 2.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.4 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 4.1 | GO:0030018 | Z disc(GO:0030018) |
| 0.3 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 2.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 3.4 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 1.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 16.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 2.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 6.3 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
| 0.2 | 3.8 | GO:0043218 | compact myelin(GO:0043218) |
| 0.2 | 6.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 1.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.2 | 1.7 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 2.3 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 6.8 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 1.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 8.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 4.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 7.2 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
| 0.1 | 3.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 2.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 3.6 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 27.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 1.7 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 1.3 | GO:0031984 | trans-Golgi network(GO:0005802) organelle subcompartment(GO:0031984) Golgi subcompartment(GO:0098791) |
| 0.1 | 1.4 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 8.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
| 0.1 | 1.2 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 4.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 3.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 3.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.4 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 9.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 2.9 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 6.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 3.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 9.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.1 | GO:0005940 | septin ring(GO:0005940) |
| 0.0 | 0.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 15.7 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.0 | 17.7 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.0 | 2.4 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 1.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 10.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.0 | 1.3 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.0 | 0.9 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 18.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
| 0.0 | 1.0 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.0 | 0.9 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 1.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 0.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 11.6 | GO:0005534 | galactose binding(GO:0005534) |
| 3.3 | 13.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 2.9 | 14.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 2.5 | 12.7 | GO:0005113 | patched binding(GO:0005113) |
| 1.9 | 5.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 1.7 | 5.0 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.5 | 10.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 1.3 | 5.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.2 | 3.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 1.1 | 11.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 1.1 | 3.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.1 | 13.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 1.1 | 5.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 1.0 | 6.1 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
| 1.0 | 2.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.9 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.8 | 22.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.8 | 8.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.7 | 3.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.7 | 4.8 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
| 0.6 | 7.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.6 | 7.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.6 | 3.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.6 | 5.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.5 | 6.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.5 | 4.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.5 | 1.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.5 | 3.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.5 | 5.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.4 | 10.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.4 | 2.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.4 | 7.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 2.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.4 | 3.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 4.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 7.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 1.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.3 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 7.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 3.4 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.3 | 2.6 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.3 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 3.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.3 | 0.8 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.2 | 3.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.2 | 0.7 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
| 0.2 | 9.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.2 | 11.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 0.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 3.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.2 | 4.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 2.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 1.0 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.2 | 7.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.2 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
| 0.2 | 1.9 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 5.3 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.2 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 3.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 3.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 3.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 3.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 4.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 13.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 3.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 5.8 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine binding(GO:0042166) |
| 0.1 | 2.1 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
| 0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
| 0.1 | 0.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
| 0.1 | 5.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 2.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 14.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 1.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 3.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 0.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.1 | 0.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) |
| 0.1 | 4.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 2.7 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
| 0.1 | 0.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.1 | 1.3 | GO:0044653 | trehalase activity(GO:0015927) dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
| 0.1 | 3.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 5.9 | GO:0005506 | iron ion binding(GO:0005506) |
| 0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 1.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 26.1 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 2.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 6.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 1.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.0 | 1.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.0 | 2.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 2.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 2.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 1.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 2.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.8 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.0 | 1.6 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 2.0 | GO:0051287 | NAD binding(GO:0051287) |
| 0.0 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.0 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 1.6 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 3.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 1.2 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 1.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.1 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
| 0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.5 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.0 | GO:0001094 | RNA polymerase II basal transcription factor binding(GO:0001091) TFIID-class transcription factor binding(GO:0001094) |
| 0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
|
|
|